Glaxosmithkline Pharmaceuticals Ltd Net Profit is INR 14.33 crores in Quarter 4, January – March of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Glaxosmithkline Pharmaceuticals Ltd Quarter Net Profit is Down by -90 % from Last Year Quarter and Net Profit of INR 14.33 crores is reported in Quarter 4, January – March of Financial Year 2020-2021. Last Year Quarter 4, January – March of Financial Year 2019-2020 Net Profit was INR 138.07 crores.
Quarterly Net Sales Year-on-Year
Glaxosmithkline Pharmaceuticals Ltd Quarter Sale is up 5 % from Last Quarter. Sales of 813.75 is reported in Quarter 4, January – March of Financial Year 2020-2021. In Last Year Quarter 4, January – March of Financial Year 2019-2020 Sale was 775.8
Annual Sales & Net Earning
Glaxosmithkline Pharmaceuticals Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 3224.38 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 93.2 crores.
Glaxosmithkline Pharmaceuticals Ltd Stock Information
| Sector | Pharmaceuticals |
| Industry | Pharmaceuticals – Multinational |
| About | GSK India is committed to providing medicines that will improve peoples quality of life and truly make a difference to patients. Their ultimate goal is to leverage the power of science through new innovations in both preventive and curative healthcare and They are a leader in many therapeutic areas where they provide healthcare solutions.( |
| Latest Qaurter EPS | 0.845506019314724 |
Glaxosmithkline Pharmaceuticals Ltd Stock Analysis:
Get more Quarterly Earnings Results of companies
Get complete data on Glaxosmithkline Pharmaceuticals Ltd
